NCT05421338View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 456906 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

November 17, 2022

Study Completion Date

November 17, 2022

Conditions
Healthy
Interventions
DRUG

BI 456906 (C-14)

BI 456906 (C-14)

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05421338 - A Study in Healthy Men to Test How BI 456906 is Processed in the Body | Biotech Hunter | Biotech Hunter